🔗 Share this article

Grammy-winning soul vocalist D’Angelo passed away on October 14 at age 51 after a private battle with pancreatic cancer.

“The brilliant light of our family has faded away for us in this life,” his relatives stated. “After a lengthy and courageous battle with the disease, we are heartbroken to announce that Michael D’Angelo Archer, known to his followers around the globe as D’Angelo, has been taken from us.”

D’Angelo left an indelible mark on the music industry with his pioneering neo-soul sound and collaborations with high-profile artists.

He launched his debut album, “Brown Sugar,” in the mid-nineties to immediate acclaim. The album achieved No. 4 on Billboard’s Top R&B Albums chart, earned platinum status later that year, and received several award nominations.

However, it was his second album, “Voodoo,” in 2000 that propelled his artistic journey into the limelight. The record debuted at No. 1 on both the R&B charts and the Billboard 200. He won two Grammy Awards: Best R&B Album and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” solidified D’Angelo’s reputation as a icon, albeit a reluctant one, in the public consciousness. The personal depiction featured the artist, notably bare to his midsection, singing directly into the lens.

D’Angelo retreated from the spotlight after releasing Voodoo and publicly struggled with drugs and alcohol. In 2005, he was involved in a severe vehicle accident that put him in grave health.

Over ten years later, his last record, “Black Messiah” (2014), reaffirmed his lasting popularity with another top chart entry on the soul music rankings and a award for Top R&B Record.

Again, in his own enigmatic fashion, D’Angelo made only a few public outings in the following years.

The singer was scheduled as a headliner for the 2025 Roots Picnic festival, but his appearance was canceled, citing an “unforeseen medical delay.”

Even though details are sparse about D’Angelo’s health in the months leading up to his passing, he had reportedly been in the hospital for an extended period and in palliative care for a fortnight.

D’Angelo’s demise is a stark reminder of the harmful impact of pancreatic cancer, one of the deadliest and least preventable types of the disease, on a brilliant talent whose life was cut short.

“We are saddened that he can only provide cherished moments with his family, but we are eternally grateful for the heritage of deeply emotional songs he has left us,” his kin expressed.

Pancreatic Malignancy: Deadly and Rarely Preventable

Pancreatic cancer impacts the digestive organ, a tiny gland that generates the hormone insulin and is vital in digestion, among other functions. The position and dimensions of the organ in the body make it more challenging to identify malignancy.

Although pancreatic cancer makes up only about 3% of cancer diagnoses annually in the U.S., it is responsible for seven percent of cancer deaths.

Almost 70,000 people will be found to have pancreatic cancer and about fifty-two thousand will die of the illness in 2025.

“Pancreatic cancer is one of the deadliest cancers, with an fast-growing mass and dismal outcomes. We have few and poor therapies, and a smaller window to make a significant difference on the lives of people,” said a cancer specialist.

Since this disease rarely causes early symptoms, it’s frequently identified only once the condition is late-stage. Although a patient has symptoms they are often vague and may be mistaken for a number of common illnesses.

“As of yet, there is no good way to detect pancreatic cancer in the initial phases, except for listening to your body and consulting your doctor if there are new or unusual signs,” said a health expert.

Frequent indicators of pancreatic cancer encompass:

• abdominal or lower back pain
• reduced body mass
• jaundice
• loss of appetite
• brownish urine
• pale or fatty bowel movements
• diarrhea
• excessive hunger or thirst
• nausea

At age 51, D’Angelo’s death is an outlier, as this malignancy is typically found in adults in the 65 to 75 age bracket. However, many cancers, including this type, have become more common among younger people.

“Pancreatic cancer diagnosed prior to fifty is considered rare, yet alarmingly, clinicians are beginning to see a growing number of younger patients affected by this disease,” commented a specialist.

Genetic Background Affects Disease Probability

In the absence of effective screening tools for this malignancy, professionals stressed the significance of knowing your family’s cancer history. Certain risk factors, such as smoking and obesity also play a role in the development of pancreatic cancer.

African Americans have the highest incidence of pancreatic cancer in the U.S. and are more prone to be diagnosed with inoperable cancer.

“The first step toward lowering one’s chance of pancreatic cancer is assessing individual susceptibility. Individuals should review their genetic background, hereditary factors, and medical conditions, such as diabetes, chronic pancreatitis, or overweight that may increase their susceptibility,” advised a specialist.

Inherited genetic risk factors are associated with as much as ten percent of all this malignancy cases. If someone in your family has had this disease, you may want to think about genetic testing.

“For individuals with a relative’s background of pancreatic cancer or those having elevated risk DNA changes, checking may involve sophisticated scans such as MRI scans or internal ultrasound to detect early changes in the pancreas,” he explained.

For those looking to lower their chance, habit adjustments may make a difference. The best action you can take to lower your risk of pancreatic cancer is to stop tobacco use, and if you don’t smoke, avoid exposure altogether.

Excessive alcohol consumption is associated with pancreatitis, a risk factor for this malignancy, so reducing or avoiding drinks may help reduce your risk.

Controlling your weight or shedding pounds may also help reduce your risk. People with obesity are twenty percent more prone to develop this disease. Pancreatic cancer also is more frequent in those with blood sugar issues, and reducing weight can also reduce the risk of type 2 diabetes.

Despite pancreatic cancer’s poor prognosis, there is still hope.

“We are doing better with treatments and more recent combination chemotherapy. There are emerging targeted therapies that already are showing results,” remarked a specialist.

For many individuals, however, awareness about this rare but {dev